Martina Reitz

Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Jens Atzpodien, Hartmut Kirchner, Udo Jonas et al. · Journal of Clinical Oncology · 2004 · 224 citations · Full text

A nine-gene signature predicting clinical outcome in cutaneous melanoma

Georg Brunner, Martina Reitz, Achim Heinecke et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 96 citations · Full text

Dermoscopic Image, Tumor Biology, Medicine +8

Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)

Jens Atzpodien, K. Neuber, Darab Kamanabrou et al. · British Journal of Cancer · 2002 · 95 citations · Full text

Combination Chemotherapy, Medicine, Melanoma +9

Thirteen‐year, long‐term efficacy of interferon 2α and interleukin 2‐based home therapy in patients with advanced renal cell carcinoma

Jens Atzpodien, Reinhard Hoffmann, Marcus Franzke et al. · Cancer · 2002 · 72 citations · Full text

Foxp3+ Regulatory T Cells Delay Expulsion of Intestinal Nematodes by Suppression of IL-9-Driven Mast Cell Activation in BALB/c but Not in C57BL/6 Mice

Birte Blankenhaus, Martina Reitz, Yannick Brenz et al. · PLoS Pathogens · 2014 · 57 citations · Full text